BridgeMD
New treatment option for Keloid Scars
Official title Topical Cryotherapy and Keloid/Hypertrophic Scars
ClinicalTrials.gov ID: NCT07336368
What this study is testing
What is Intralesional Triamcinolone 10 mg/ml?
Intralesional Triamcinolone 10 mg/ml is an investigational medicine, given as a treatment applied to the skin, being studied as a potential treatment for keloid scars.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to determine whether the application of brief topical cryotherapy immediately before intralesional corticosteroid injections can reduce pain and injection resistance during routine treatment of keloid and hypertrophic scars in adult patients. The main questions it aims to answer are: Does topical cryotherapy applied before intralesional triamcinolone injection impact pain perceptions for participants with keloids or hypertrophic scars?
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults (≥18 years) with keloids or hypertrophic scars already scheduled to receive intralesional triamcinolone (TAC) as part of routine care.
- At least one keloid or hypertrophic scar with two comparable regions (≥2 cm each) suitable for split-treatment.
- Able to provide informed consent and complete pain assessments in English.
You likely can't join if
- Keloid or hypertrophic scar located on the face (except earlobes), excluded for cosmetic reasons.
- Prior treatment to the study-selected keloid/hypertrophic scar based on self-report.
- Inability to complete study assessments due to cognitive or language barriers.
The study team makes the final eligibility decision.
Where it's taking place
- Pittsburgh, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pittsburgh, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.